Poltreg S.A. (PTG.WA)
PLN 35.0
(4.17%)
PLN 35.0
(4.17%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -2.91 PLN | -1139.29% |
| 2022 | 0.28 PLN | 125.23% |
| 2021 | -1.11 PLN | -270.0% |
| 2020 | -0.30 PLN | 14.29% |
| 2019 | -0.35 PLN | 14.63% |
| 2018 | -0.41 PLN | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.72 PLN | 20.0% |
| 2024 Q2 | -1.06 PLN | -47.22% |
| 2023 Q2 | -0.68 PLN | -783.12% |
| 2023 Q4 | -0.90 PLN | 15.09% |
| 2023 FY | - PLN | -1139.29% |
| 2023 Q1 | -0.08 PLN | 48.67% |
| 2023 Q3 | -1.06 PLN | -55.88% |
| 2022 FY | - PLN | 125.23% |
| 2022 Q4 | -0.15 PLN | -299.2% |
| 2022 Q3 | 0.08 PLN | 345.56% |
| 2022 Q2 | 0.02 PLN | 108.45% |
| 2022 Q1 | -0.20 PLN | 69.23% |
| 2021 Q1 | -0.11 PLN | -62.96% |
| 2021 FY | - PLN | -270.0% |
| 2021 Q4 | -0.65 PLN | -132.14% |
| 2021 Q3 | -0.28 PLN | -279.4% |
| 2021 Q2 | -0.07 PLN | 32.91% |
| 2020 Q2 | -0.11 PLN | 0.0% |
| 2020 Q3 | -0.07 PLN | 36.36% |
| 2020 Q4 | -0.07 PLN | 3.57% |
| 2020 FY | - PLN | 14.29% |
| 2020 Q1 | -0.11 PLN | 0.0% |
| 2019 FY | - PLN | 14.63% |
| 2018 FY | - PLN | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Bioceltix S.A. | -3.49 PLN | 16.619% |
| BIOTON S.A. | 0.03 PLN | 11081.132% |
| Captor Therapeutics Spolka Akcyjna | -15.19 PLN | 80.843% |
| Mabion S.A. | 2.55 PLN | 214.118% |
| Molecure S.A. | -1.09 PLN | -166.972% |
| NanoGroup S.A. | -0.39 PLN | -646.154% |
| Pharmena S.A. | 2.60 PLN | 211.923% |
| Pure Biologics Spólka Akcyjna | -11.19 PLN | 73.995% |
| Ryvu Therapeutics S.A. | -4.02 PLN | 27.612% |
| Synthaverse S.A. | 0.07 PLN | 4398.375% |
| Urteste S.A. | -4.32 PLN | 32.639% |